nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Headache—Mitomycin—stomach cancer	0.00376	0.00421	CcSEcCtD
Nalbuphine—Bradycardia—Irinotecan—stomach cancer	0.00373	0.00419	CcSEcCtD
Nalbuphine—Nausea—Mitomycin—stomach cancer	0.00356	0.004	CcSEcCtD
Nalbuphine—Hypoaesthesia—Fluorouracil—stomach cancer	0.00349	0.00392	CcSEcCtD
Nalbuphine—Flushing—Irinotecan—stomach cancer	0.0034	0.00382	CcSEcCtD
Nalbuphine—Injection site reaction—Epirubicin—stomach cancer	0.00338	0.0038	CcSEcCtD
Nalbuphine—Cardiac arrest—Capecitabine—stomach cancer	0.00337	0.00378	CcSEcCtD
Nalbuphine—Cramp muscle—Docetaxel—stomach cancer	0.0033	0.0037	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methotrexate—stomach cancer	0.00324	0.00363	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—stomach cancer	0.00313	0.00351	CcSEcCtD
Nalbuphine—Bronchospasm—Docetaxel—stomach cancer	0.00311	0.00349	CcSEcCtD
Nalbuphine—Muscle spasms—Irinotecan—stomach cancer	0.00307	0.00344	CcSEcCtD
Nalbuphine—Asthma—Capecitabine—stomach cancer	0.00306	0.00344	CcSEcCtD
Nalbuphine—Erythema—Fluorouracil—stomach cancer	0.00306	0.00343	CcSEcCtD
Nalbuphine—Pulmonary oedema—Epirubicin—stomach cancer	0.00303	0.0034	CcSEcCtD
Nalbuphine—Bronchospasm—Capecitabine—stomach cancer	0.00301	0.00338	CcSEcCtD
Nalbuphine—Sweating increased—Capecitabine—stomach cancer	0.00299	0.00335	CcSEcCtD
Nalbuphine—Vision blurred—Fluorouracil—stomach cancer	0.00288	0.00323	CcSEcCtD
Nalbuphine—Vertigo—Irinotecan—stomach cancer	0.00287	0.00322	CcSEcCtD
Nalbuphine—Syncope—Irinotecan—stomach cancer	0.00286	0.00321	CcSEcCtD
Nalbuphine—Loss of consciousness—Irinotecan—stomach cancer	0.0028	0.00315	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—stomach cancer	0.0028	0.00314	CcSEcCtD
Nalbuphine—Hypertension—Irinotecan—stomach cancer	0.00275	0.00309	CcSEcCtD
Nalbuphine—Depression—Capecitabine—stomach cancer	0.00272	0.00306	CcSEcCtD
Nalbuphine—Convulsion—Fluorouracil—stomach cancer	0.00265	0.00297	CcSEcCtD
Nalbuphine—Confusional state—Irinotecan—stomach cancer	0.00263	0.00295	CcSEcCtD
Nalbuphine—Oedema—Irinotecan—stomach cancer	0.0026	0.00292	CcSEcCtD
Nalbuphine—Shock—Irinotecan—stomach cancer	0.00256	0.00287	CcSEcCtD
Nalbuphine—Hypoaesthesia—Docetaxel—stomach cancer	0.00252	0.00283	CcSEcCtD
Nalbuphine—Hyperhidrosis—Irinotecan—stomach cancer	0.00252	0.00282	CcSEcCtD
Nalbuphine—Confusional state—Fluorouracil—stomach cancer	0.00251	0.00282	CcSEcCtD
Nalbuphine—Bradycardia—Capecitabine—stomach cancer	0.0025	0.0028	CcSEcCtD
Nalbuphine—Oedema—Fluorouracil—stomach cancer	0.00249	0.0028	CcSEcCtD
Nalbuphine—Hypoaesthesia—Capecitabine—stomach cancer	0.00244	0.00274	CcSEcCtD
Nalbuphine—Tachycardia—Fluorouracil—stomach cancer	0.00243	0.00273	CcSEcCtD
Nalbuphine—Hypotension—Irinotecan—stomach cancer	0.00243	0.00273	CcSEcCtD
Nalbuphine—Flushing—Docetaxel—stomach cancer	0.00235	0.00264	CcSEcCtD
Nalbuphine—Cardiac arrest—Epirubicin—stomach cancer	0.00235	0.00264	CcSEcCtD
Nalbuphine—Paraesthesia—Irinotecan—stomach cancer	0.00234	0.00262	CcSEcCtD
Nalbuphine—Hypotension—Fluorouracil—stomach cancer	0.00233	0.00261	CcSEcCtD
Nalbuphine—Dyspnoea—Irinotecan—stomach cancer	0.00232	0.0026	CcSEcCtD
Nalbuphine—Somnolence—Irinotecan—stomach cancer	0.00231	0.0026	CcSEcCtD
Nalbuphine—Dyspepsia—Irinotecan—stomach cancer	0.00229	0.00257	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—stomach cancer	0.00228	0.00256	CcSEcCtD
Nalbuphine—Flushing—Capecitabine—stomach cancer	0.00228	0.00255	CcSEcCtD
Nalbuphine—Paraesthesia—Fluorouracil—stomach cancer	0.00224	0.00251	CcSEcCtD
Nalbuphine—Dyspnoea—Fluorouracil—stomach cancer	0.00222	0.00249	CcSEcCtD
Nalbuphine—Somnolence—Fluorouracil—stomach cancer	0.00222	0.00249	CcSEcCtD
Nalbuphine—Erythema—Docetaxel—stomach cancer	0.00221	0.00247	CcSEcCtD
Nalbuphine—Dyspepsia—Fluorouracil—stomach cancer	0.0022	0.00246	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—stomach cancer	0.00217	0.00244	CcSEcCtD
Nalbuphine—Dysgeusia—Docetaxel—stomach cancer	0.00216	0.00242	CcSEcCtD
Nalbuphine—Feeling abnormal—Irinotecan—stomach cancer	0.00215	0.00241	CcSEcCtD
Nalbuphine—Erythema—Capecitabine—stomach cancer	0.00214	0.0024	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—stomach cancer	0.00214	0.0024	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Irinotecan—stomach cancer	0.00213	0.00239	CcSEcCtD
Nalbuphine—Muscle spasms—Docetaxel—stomach cancer	0.00212	0.00238	CcSEcCtD
Nalbuphine—Dysgeusia—Capecitabine—stomach cancer	0.00209	0.00235	CcSEcCtD
Nalbuphine—Abdominal pain—Irinotecan—stomach cancer	0.00206	0.00231	CcSEcCtD
Nalbuphine—Body temperature increased—Irinotecan—stomach cancer	0.00206	0.00231	CcSEcCtD
Nalbuphine—Feeling abnormal—Fluorouracil—stomach cancer	0.00206	0.00231	CcSEcCtD
Nalbuphine—Muscle spasms—Capecitabine—stomach cancer	0.00205	0.0023	CcSEcCtD
Nalbuphine—Depression—Methotrexate—stomach cancer	0.00203	0.00228	CcSEcCtD
Nalbuphine—Vision blurred—Capecitabine—stomach cancer	0.00201	0.00226	CcSEcCtD
Nalbuphine—Tremor—Capecitabine—stomach cancer	0.002	0.00224	CcSEcCtD
Nalbuphine—Urticaria—Fluorouracil—stomach cancer	0.00198	0.00222	CcSEcCtD
Nalbuphine—Syncope—Docetaxel—stomach cancer	0.00198	0.00222	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—stomach cancer	0.00198	0.00222	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—stomach cancer	0.00197	0.00221	CcSEcCtD
Nalbuphine—Body temperature increased—Fluorouracil—stomach cancer	0.00197	0.00221	CcSEcCtD
Nalbuphine—Loss of consciousness—Docetaxel—stomach cancer	0.00194	0.00217	CcSEcCtD
Nalbuphine—Vertigo—Capecitabine—stomach cancer	0.00192	0.00215	CcSEcCtD
Nalbuphine—Hypersensitivity—Irinotecan—stomach cancer	0.00192	0.00215	CcSEcCtD
Nalbuphine—Syncope—Capecitabine—stomach cancer	0.00191	0.00215	CcSEcCtD
Nalbuphine—Convulsion—Docetaxel—stomach cancer	0.00191	0.00214	CcSEcCtD
Nalbuphine—Hypertension—Docetaxel—stomach cancer	0.0019	0.00214	CcSEcCtD
Nalbuphine—Loss of consciousness—Capecitabine—stomach cancer	0.00188	0.00211	CcSEcCtD
Nalbuphine—Asthenia—Irinotecan—stomach cancer	0.00187	0.0021	CcSEcCtD
Nalbuphine—Hypertension—Capecitabine—stomach cancer	0.00184	0.00207	CcSEcCtD
Nalbuphine—Hypersensitivity—Fluorouracil—stomach cancer	0.00184	0.00206	CcSEcCtD
Nalbuphine—Dry mouth—Docetaxel—stomach cancer	0.00184	0.00206	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—stomach cancer	0.00182	0.00205	CcSEcCtD
Nalbuphine—Confusional state—Docetaxel—stomach cancer	0.00181	0.00204	CcSEcCtD
Nalbuphine—Anxiety—Capecitabine—stomach cancer	0.00181	0.00203	CcSEcCtD
Nalbuphine—Oedema—Docetaxel—stomach cancer	0.0018	0.00202	CcSEcCtD
Nalbuphine—Dry mouth—Capecitabine—stomach cancer	0.00178	0.00199	CcSEcCtD
Nalbuphine—Shock—Docetaxel—stomach cancer	0.00177	0.00199	CcSEcCtD
Nalbuphine—Pruritus—Fluorouracil—stomach cancer	0.00176	0.00198	CcSEcCtD
Nalbuphine—Confusional state—Capecitabine—stomach cancer	0.00176	0.00197	CcSEcCtD
Nalbuphine—Tachycardia—Docetaxel—stomach cancer	0.00176	0.00197	CcSEcCtD
Nalbuphine—Oedema—Capecitabine—stomach cancer	0.00174	0.00196	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—stomach cancer	0.00174	0.00195	CcSEcCtD
Nalbuphine—Dizziness—Irinotecan—stomach cancer	0.00172	0.00193	CcSEcCtD
Nalbuphine—Shock—Capecitabine—stomach cancer	0.00171	0.00192	CcSEcCtD
Nalbuphine—Tachycardia—Capecitabine—stomach cancer	0.0017	0.00191	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—stomach cancer	0.0017	0.00191	CcSEcCtD
Nalbuphine—Hyperhidrosis—Capecitabine—stomach cancer	0.00168	0.00189	CcSEcCtD
Nalbuphine—Hypotension—Docetaxel—stomach cancer	0.00168	0.00189	CcSEcCtD
Nalbuphine—Vomiting—Irinotecan—stomach cancer	0.00166	0.00186	CcSEcCtD
Nalbuphine—Dizziness—Fluorouracil—stomach cancer	0.00165	0.00185	CcSEcCtD
Nalbuphine—Rash—Irinotecan—stomach cancer	0.00164	0.00184	CcSEcCtD
Nalbuphine—Dermatitis—Irinotecan—stomach cancer	0.00164	0.00184	CcSEcCtD
Nalbuphine—Headache—Irinotecan—stomach cancer	0.00163	0.00183	CcSEcCtD
Nalbuphine—Hypotension—Capecitabine—stomach cancer	0.00163	0.00183	CcSEcCtD
Nalbuphine—Paraesthesia—Docetaxel—stomach cancer	0.00162	0.00181	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—stomach cancer	0.00161	0.00181	CcSEcCtD
Nalbuphine—Dyspnoea—Docetaxel—stomach cancer	0.0016	0.0018	CcSEcCtD
Nalbuphine—Somnolence—Docetaxel—stomach cancer	0.0016	0.0018	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—stomach cancer	0.00159	0.00178	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—stomach cancer	0.00159	0.00178	CcSEcCtD
Nalbuphine—Vomiting—Fluorouracil—stomach cancer	0.00159	0.00178	CcSEcCtD
Nalbuphine—Dyspepsia—Docetaxel—stomach cancer	0.00158	0.00178	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—stomach cancer	0.00157	0.00176	CcSEcCtD
Nalbuphine—Rash—Fluorouracil—stomach cancer	0.00157	0.00176	CcSEcCtD
Nalbuphine—Dermatitis—Fluorouracil—stomach cancer	0.00157	0.00176	CcSEcCtD
Nalbuphine—Paraesthesia—Capecitabine—stomach cancer	0.00156	0.00176	CcSEcCtD
Nalbuphine—Headache—Fluorouracil—stomach cancer	0.00156	0.00175	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—stomach cancer	0.00156	0.00175	CcSEcCtD
Nalbuphine—Dyspnoea—Capecitabine—stomach cancer	0.00155	0.00174	CcSEcCtD
Nalbuphine—Nausea—Irinotecan—stomach cancer	0.00155	0.00174	CcSEcCtD
Nalbuphine—Dyspepsia—Capecitabine—stomach cancer	0.00153	0.00172	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—stomach cancer	0.0015	0.00168	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—stomach cancer	0.00149	0.00167	CcSEcCtD
Nalbuphine—Feeling abnormal—Docetaxel—stomach cancer	0.00148	0.00166	CcSEcCtD
Nalbuphine—Nausea—Fluorouracil—stomach cancer	0.00148	0.00166	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00147	0.00165	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—stomach cancer	0.00147	0.00165	CcSEcCtD
Nalbuphine—Tension—Epirubicin—stomach cancer	0.00146	0.00164	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—stomach cancer	0.00146	0.00163	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—stomach cancer	0.00144	0.00162	CcSEcCtD
Nalbuphine—Feeling abnormal—Capecitabine—stomach cancer	0.00144	0.00161	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—stomach cancer	0.00143	0.0016	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—stomach cancer	0.00143	0.0016	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Capecitabine—stomach cancer	0.00143	0.0016	CcSEcCtD
Nalbuphine—Body temperature increased—Docetaxel—stomach cancer	0.00142	0.0016	CcSEcCtD
Nalbuphine—Abdominal pain—Docetaxel—stomach cancer	0.00142	0.0016	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—stomach cancer	0.0014	0.00157	CcSEcCtD
Nalbuphine—Urticaria—Capecitabine—stomach cancer	0.00138	0.00155	CcSEcCtD
Nalbuphine—Body temperature increased—Capecitabine—stomach cancer	0.00138	0.00155	CcSEcCtD
Nalbuphine—Abdominal pain—Capecitabine—stomach cancer	0.00138	0.00155	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—stomach cancer	0.00138	0.00155	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—stomach cancer	0.00138	0.00154	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—stomach cancer	0.00137	0.00153	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—stomach cancer	0.00135	0.00152	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—stomach cancer	0.00135	0.00151	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—stomach cancer	0.00134	0.0015	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—stomach cancer	0.00134	0.0015	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—stomach cancer	0.00133	0.0015	CcSEcCtD
Nalbuphine—Hypersensitivity—Docetaxel—stomach cancer	0.00133	0.00149	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—stomach cancer	0.00132	0.00148	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—stomach cancer	0.00131	0.00147	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—stomach cancer	0.00131	0.00147	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—stomach cancer	0.0013	0.00146	CcSEcCtD
Nalbuphine—Asthenia—Docetaxel—stomach cancer	0.00129	0.00145	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—stomach cancer	0.00129	0.00145	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—stomach cancer	0.00128	0.00144	CcSEcCtD
Nalbuphine—Hypersensitivity—Capecitabine—stomach cancer	0.00128	0.00144	CcSEcCtD
Nalbuphine—Pruritus—Docetaxel—stomach cancer	0.00127	0.00143	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—stomach cancer	0.00126	0.00142	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—stomach cancer	0.00126	0.00142	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—stomach cancer	0.00125	0.00141	CcSEcCtD
Nalbuphine—Asthenia—Capecitabine—stomach cancer	0.00125	0.0014	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—stomach cancer	0.00124	0.00139	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—stomach cancer	0.00124	0.00139	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—stomach cancer	0.00123	0.00138	CcSEcCtD
Nalbuphine—Pruritus—Capecitabine—stomach cancer	0.00123	0.00138	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—stomach cancer	0.00122	0.00137	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—stomach cancer	0.00121	0.00136	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—stomach cancer	0.00121	0.00136	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—stomach cancer	0.00121	0.00136	CcSEcCtD
Nalbuphine—Shock—Epirubicin—stomach cancer	0.00119	0.00134	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—stomach cancer	0.00119	0.00134	CcSEcCtD
Nalbuphine—Dizziness—Docetaxel—stomach cancer	0.00119	0.00134	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—stomach cancer	0.00119	0.00133	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—stomach cancer	0.00118	0.00133	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—stomach cancer	0.00117	0.00132	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—stomach cancer	0.00117	0.00131	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—stomach cancer	0.00116	0.00131	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—stomach cancer	0.00116	0.0013	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—stomach cancer	0.00115	0.00129	CcSEcCtD
Nalbuphine—Dizziness—Capecitabine—stomach cancer	0.00115	0.00129	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—stomach cancer	0.00115	0.00129	CcSEcCtD
Nalbuphine—Vomiting—Docetaxel—stomach cancer	0.00114	0.00128	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—stomach cancer	0.00114	0.00128	CcSEcCtD
Nalbuphine—Rash—Docetaxel—stomach cancer	0.00113	0.00127	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—stomach cancer	0.00113	0.00127	CcSEcCtD
Nalbuphine—Dermatitis—Docetaxel—stomach cancer	0.00113	0.00127	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—stomach cancer	0.00113	0.00127	CcSEcCtD
Nalbuphine—Headache—Docetaxel—stomach cancer	0.00113	0.00127	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—stomach cancer	0.00112	0.00126	CcSEcCtD
Nalbuphine—Vomiting—Capecitabine—stomach cancer	0.00111	0.00124	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—stomach cancer	0.00111	0.00124	CcSEcCtD
Nalbuphine—Rash—Capecitabine—stomach cancer	0.0011	0.00123	CcSEcCtD
Nalbuphine—Dermatitis—Capecitabine—stomach cancer	0.0011	0.00123	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—stomach cancer	0.0011	0.00123	CcSEcCtD
Nalbuphine—Headache—Capecitabine—stomach cancer	0.00109	0.00122	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—stomach cancer	0.00109	0.00122	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—stomach cancer	0.00109	0.00122	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—stomach cancer	0.00108	0.00121	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—stomach cancer	0.00108	0.00121	CcSEcCtD
Nalbuphine—Nausea—Docetaxel—stomach cancer	0.00107	0.0012	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—stomach cancer	0.00107	0.0012	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—stomach cancer	0.00107	0.0012	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—stomach cancer	0.00106	0.00119	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—stomach cancer	0.00105	0.00118	CcSEcCtD
Nalbuphine—Nausea—Capecitabine—stomach cancer	0.00104	0.00116	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—stomach cancer	0.00103	0.00116	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—stomach cancer	0.00103	0.00115	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—stomach cancer	0.00103	0.00115	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—stomach cancer	0.00101	0.00113	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—stomach cancer	0.001	0.00112	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—stomach cancer	0.001	0.00112	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—stomach cancer	0.000999	0.00112	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000993	0.00111	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—stomach cancer	0.000989	0.00111	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—stomach cancer	0.000965	0.00108	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—stomach cancer	0.00096	0.00108	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—stomach cancer	0.00096	0.00108	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—stomach cancer	0.000956	0.00107	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—stomach cancer	0.000931	0.00104	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—stomach cancer	0.000926	0.00104	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000919	0.00103	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—stomach cancer	0.000918	0.00103	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—stomach cancer	0.000895	0.001	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—stomach cancer	0.000892	0.001	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—stomach cancer	0.000888	0.000996	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—stomach cancer	0.000888	0.000996	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—stomach cancer	0.000871	0.000977	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—stomach cancer	0.000859	0.000964	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—stomach cancer	0.000858	0.000962	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—stomach cancer	0.000828	0.000928	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—stomach cancer	0.000825	0.000925	CcSEcCtD
Nalbuphine—Rash—Methotrexate—stomach cancer	0.000818	0.000918	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—stomach cancer	0.000817	0.000917	CcSEcCtD
Nalbuphine—Headache—Methotrexate—stomach cancer	0.000813	0.000912	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—stomach cancer	0.000806	0.000904	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—stomach cancer	0.000803	0.000901	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—stomach cancer	0.000795	0.000892	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—stomach cancer	0.000772	0.000866	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—stomach cancer	0.000771	0.000864	CcSEcCtD
Nalbuphine—Rash—Epirubicin—stomach cancer	0.000766	0.000859	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—stomach cancer	0.000765	0.000858	CcSEcCtD
Nalbuphine—Headache—Epirubicin—stomach cancer	0.000761	0.000853	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—stomach cancer	0.000743	0.000833	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—stomach cancer	0.000721	0.000809	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—stomach cancer	0.000714	0.000801	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—stomach cancer	0.000708	0.000795	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—stomach cancer	0.000708	0.000794	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—stomach cancer	0.000704	0.000789	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—stomach cancer	0.000667	0.000749	CcSEcCtD
Nalbuphine—Buprenorphine—CYP2A6—stomach cancer	0.000585	0.721	CrCbGaD
Nalbuphine—Naloxone—ALB—stomach cancer	0.000226	0.279	CrCbGaD
Nalbuphine—OPRD1—Signaling by GPCR—ANXA1—stomach cancer	0.000183	0.0017	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—HTR1A—stomach cancer	0.000183	0.0017	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RNF43—stomach cancer	0.000179	0.00166	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KISS1—stomach cancer	0.000179	0.00166	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000178	0.00165	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRB1—stomach cancer	0.000178	0.00165	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ANXA1—stomach cancer	0.000177	0.00164	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—WIF1—stomach cancer	0.000176	0.00163	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HRH4—stomach cancer	0.000176	0.00163	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGTR2—stomach cancer	0.000173	0.0016	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRB1—stomach cancer	0.000171	0.00159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—F2R—stomach cancer	0.000171	0.00159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HTR1A—stomach cancer	0.000166	0.00154	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCL8—stomach cancer	0.000166	0.00154	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKAB1—stomach cancer	0.000162	0.00151	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGTR2—stomach cancer	0.000161	0.00149	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ANXA1—stomach cancer	0.000161	0.00149	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—WWOX—stomach cancer	0.00016	0.00148	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FST—stomach cancer	0.000159	0.00148	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—F2R—stomach cancer	0.000159	0.00148	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADRB2—stomach cancer	0.000158	0.00147	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KISS1—stomach cancer	0.000157	0.00145	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RNF43—stomach cancer	0.000157	0.00145	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000156	0.00145	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HBEGF—stomach cancer	0.000156	0.00145	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRB1—stomach cancer	0.000156	0.00144	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—HTR1A—stomach cancer	0.000155	0.00144	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RGS2—stomach cancer	0.000154	0.00143	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GAST—stomach cancer	0.000154	0.00143	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ANXA1—stomach cancer	0.00015	0.00139	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HRH4—stomach cancer	0.000149	0.00138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—WIF1—stomach cancer	0.000149	0.00138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGTR2—stomach cancer	0.000146	0.00136	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGG—stomach cancer	0.000146	0.00135	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRB1—stomach cancer	0.000145	0.00134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—F2R—stomach cancer	0.000145	0.00134	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRB2—stomach cancer	0.000144	0.00133	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000141	0.00131	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HTR1A—stomach cancer	0.000141	0.00131	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKAA1—stomach cancer	0.00014	0.0013	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FST—stomach cancer	0.00014	0.0013	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRB2—stomach cancer	0.000139	0.00129	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKAB1—stomach cancer	0.000137	0.00127	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HBEGF—stomach cancer	0.000137	0.00127	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ANXA1—stomach cancer	0.000136	0.00126	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RBP4—stomach cancer	0.000135	0.00126	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL8—stomach cancer	0.000135	0.00126	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GAST—stomach cancer	0.000135	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RGS2—stomach cancer	0.000135	0.00125	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KISS1—stomach cancer	0.000132	0.00123	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RNF43—stomach cancer	0.000132	0.00123	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000132	0.00122	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRB1—stomach cancer	0.000132	0.00122	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGG—stomach cancer	0.000128	0.00119	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRB2—stomach cancer	0.000126	0.00117	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000124	0.00115	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKAA1—stomach cancer	0.000123	0.00114	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RBP4—stomach cancer	0.000119	0.0011	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL8—stomach cancer	0.000119	0.0011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FST—stomach cancer	0.000118	0.0011	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRB2—stomach cancer	0.000117	0.00109	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HSPB1—stomach cancer	0.000117	0.00108	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGTR2—stomach cancer	0.000117	0.00108	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HBEGF—stomach cancer	0.000116	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BMP2—stomach cancer	0.000115	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—F2R—stomach cancer	0.000115	0.00107	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GAST—stomach cancer	0.000114	0.00106	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RGS2—stomach cancer	0.000114	0.00106	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKR1C3—stomach cancer	0.000113	0.00105	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HTR1A—stomach cancer	0.000112	0.00104	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PRKCB—stomach cancer	0.000109	0.00101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ANXA1—stomach cancer	0.000108	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGG—stomach cancer	0.000108	0.001	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRB2—stomach cancer	0.000107	0.000989	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB1—stomach cancer	0.000105	0.000973	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000104	0.00097	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKAA1—stomach cancer	0.000104	0.000965	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HSPB1—stomach cancer	0.000102	0.000948	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGTR2—stomach cancer	0.000102	0.000948	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—F2R—stomach cancer	0.000101	0.000937	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BMP2—stomach cancer	0.000101	0.000937	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RBP4—stomach cancer	0.0001	0.000932	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL8—stomach cancer	0.0001	0.000931	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RPS6—stomach cancer	0.0001	0.00093	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKR1C3—stomach cancer	9.94e-05	0.000922	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PRKCB—stomach cancer	9.86e-05	0.000915	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HTR1A—stomach cancer	9.83e-05	0.000912	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6ST—stomach cancer	9.82e-05	0.000911	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PRKCB—stomach cancer	9.52e-05	0.000884	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ANXA1—stomach cancer	9.5e-05	0.000881	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HBEGF—stomach cancer	9.21e-05	0.000855	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB1—stomach cancer	9.2e-05	0.000853	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RPS6—stomach cancer	8.79e-05	0.000815	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6R—stomach cancer	8.76e-05	0.000813	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—RHOA—stomach cancer	8.72e-05	0.000809	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PRKCB—stomach cancer	8.65e-05	0.000802	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HSPB1—stomach cancer	8.63e-05	0.000801	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGTR2—stomach cancer	8.63e-05	0.000801	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6ST—stomach cancer	8.61e-05	0.000799	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—F2R—stomach cancer	8.54e-05	0.000792	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BMP2—stomach cancer	8.54e-05	0.000792	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB2—stomach cancer	8.5e-05	0.000789	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKR1C3—stomach cancer	8.4e-05	0.000779	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PPP2R1A—stomach cancer	8.33e-05	0.000773	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HTR1A—stomach cancer	8.31e-05	0.000771	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HBEGF—stomach cancer	8.08e-05	0.000749	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PRKCB—stomach cancer	8.05e-05	0.000747	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ANXA1—stomach cancer	8.03e-05	0.000745	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—RHOA—stomach cancer	7.92e-05	0.000734	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB1—stomach cancer	7.77e-05	0.000721	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SMAD4—stomach cancer	7.73e-05	0.000718	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6R—stomach cancer	7.68e-05	0.000713	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—stomach cancer	7.65e-05	0.00071	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—RHOA—stomach cancer	7.64e-05	0.000709	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB2—stomach cancer	7.45e-05	0.000692	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RPS6—stomach cancer	7.43e-05	0.000689	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FYN—stomach cancer	7.34e-05	0.000681	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PRKCB—stomach cancer	7.31e-05	0.000678	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PPP2R1A—stomach cancer	7.3e-05	0.000678	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6ST—stomach cancer	7.28e-05	0.000675	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—stomach cancer	6.95e-05	0.000645	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—RHOA—stomach cancer	6.94e-05	0.000644	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGFR2—stomach cancer	6.89e-05	0.00064	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HBEGF—stomach cancer	6.83e-05	0.000633	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SMAD4—stomach cancer	6.78e-05	0.000629	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—stomach cancer	6.71e-05	0.000623	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6R—stomach cancer	6.49e-05	0.000603	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—RHOA—stomach cancer	6.46e-05	0.000599	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FYN—stomach cancer	6.44e-05	0.000597	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS2—stomach cancer	6.31e-05	0.000586	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB2—stomach cancer	6.3e-05	0.000584	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PPP2R1A—stomach cancer	6.17e-05	0.000573	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CAV1—stomach cancer	6.12e-05	0.000568	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOA1—stomach cancer	6.11e-05	0.000567	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—stomach cancer	6.09e-05	0.000565	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGFR2—stomach cancer	6.04e-05	0.000561	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RHOA—stomach cancer	5.87e-05	0.000544	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCB—stomach cancer	5.83e-05	0.000541	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6ST—stomach cancer	5.8e-05	0.000538	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SMAD4—stomach cancer	5.73e-05	0.000532	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—stomach cancer	5.67e-05	0.000526	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APC—stomach cancer	5.57e-05	0.000517	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS2—stomach cancer	5.54e-05	0.000514	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FYN—stomach cancer	5.44e-05	0.000505	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CAV1—stomach cancer	5.37e-05	0.000498	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOA1—stomach cancer	5.35e-05	0.000497	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK3—stomach cancer	5.34e-05	0.000495	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6R—stomach cancer	5.18e-05	0.00048	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—stomach cancer	5.15e-05	0.000478	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGFR2—stomach cancer	5.11e-05	0.000474	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCB—stomach cancer	5.11e-05	0.000474	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6ST—stomach cancer	5.09e-05	0.000472	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK1—stomach cancer	5.08e-05	0.000471	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—stomach cancer	5.08e-05	0.000471	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APC—stomach cancer	4.89e-05	0.000454	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—stomach cancer	4.85e-05	0.00045	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SERPINE1—stomach cancer	4.85e-05	0.00045	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KRAS—stomach cancer	4.8e-05	0.000445	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK3—stomach cancer	4.68e-05	0.000434	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS2—stomach cancer	4.68e-05	0.000434	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RHOA—stomach cancer	4.68e-05	0.000434	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOS3—stomach cancer	4.63e-05	0.000429	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6R—stomach cancer	4.54e-05	0.000421	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CAV1—stomach cancer	4.54e-05	0.000421	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOA1—stomach cancer	4.53e-05	0.00042	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK1—stomach cancer	4.45e-05	0.000413	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—stomach cancer	4.45e-05	0.000413	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—stomach cancer	4.41e-05	0.000409	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB2—stomach cancer	4.33e-05	0.000402	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCB—stomach cancer	4.32e-05	0.000401	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6ST—stomach cancer	4.3e-05	0.000399	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—stomach cancer	4.26e-05	0.000395	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SERPINE1—stomach cancer	4.25e-05	0.000394	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KRAS—stomach cancer	4.21e-05	0.00039	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APC—stomach cancer	4.13e-05	0.000383	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—stomach cancer	4.11e-05	0.000381	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RHOA—stomach cancer	4.1e-05	0.00038	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HRAS—stomach cancer	4.08e-05	0.000378	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOS3—stomach cancer	4.06e-05	0.000377	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1B—stomach cancer	4.01e-05	0.000372	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK3—stomach cancer	3.96e-05	0.000367	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—stomach cancer	3.9e-05	0.000362	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—stomach cancer	3.87e-05	0.000359	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6R—stomach cancer	3.84e-05	0.000356	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCND1—stomach cancer	3.82e-05	0.000355	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JUN—stomach cancer	3.82e-05	0.000354	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB2—stomach cancer	3.8e-05	0.000352	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK1—stomach cancer	3.76e-05	0.000349	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—stomach cancer	3.76e-05	0.000349	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—stomach cancer	3.71e-05	0.000345	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1A—stomach cancer	3.7e-05	0.000343	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK8—stomach cancer	3.61e-05	0.000335	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—stomach cancer	3.6e-05	0.000334	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—stomach cancer	3.6e-05	0.000334	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SERPINE1—stomach cancer	3.59e-05	0.000333	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HRAS—stomach cancer	3.58e-05	0.000332	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KRAS—stomach cancer	3.56e-05	0.00033	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1B—stomach cancer	3.52e-05	0.000326	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RHOA—stomach cancer	3.47e-05	0.000322	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOS3—stomach cancer	3.43e-05	0.000318	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—stomach cancer	3.42e-05	0.000318	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCND1—stomach cancer	3.35e-05	0.000311	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JUN—stomach cancer	3.35e-05	0.00031	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—stomach cancer	3.33e-05	0.000309	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—stomach cancer	3.3e-05	0.000306	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—stomach cancer	3.27e-05	0.000303	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—stomach cancer	3.26e-05	0.000302	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1A—stomach cancer	3.24e-05	0.000301	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB2—stomach cancer	3.21e-05	0.000298	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK8—stomach cancer	3.17e-05	0.000294	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK3—stomach cancer	3.15e-05	0.000293	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—stomach cancer	3.07e-05	0.000285	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—stomach cancer	3.04e-05	0.000282	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HRAS—stomach cancer	3.02e-05	0.00028	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK1—stomach cancer	3e-05	0.000278	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—stomach cancer	3e-05	0.000278	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1B—stomach cancer	2.97e-05	0.000276	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—stomach cancer	2.92e-05	0.000271	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—stomach cancer	2.89e-05	0.000269	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—stomach cancer	2.89e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KRAS—stomach cancer	2.83e-05	0.000263	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCND1—stomach cancer	2.83e-05	0.000263	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JUN—stomach cancer	2.83e-05	0.000262	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK3—stomach cancer	2.77e-05	0.000257	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—stomach cancer	2.75e-05	0.000255	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1A—stomach cancer	2.74e-05	0.000254	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—stomach cancer	2.69e-05	0.00025	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK8—stomach cancer	2.68e-05	0.000248	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK1—stomach cancer	2.63e-05	0.000244	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—stomach cancer	2.63e-05	0.000244	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—stomach cancer	2.6e-05	0.000242	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—stomach cancer	2.52e-05	0.000234	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KRAS—stomach cancer	2.49e-05	0.000231	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—stomach cancer	2.47e-05	0.000229	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—stomach cancer	2.45e-05	0.000227	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HRAS—stomach cancer	2.41e-05	0.000224	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK3—stomach cancer	2.34e-05	0.000217	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—stomach cancer	2.31e-05	0.000214	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	2.28e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—stomach cancer	2.27e-05	0.000211	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK1—stomach cancer	2.22e-05	0.000206	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—stomach cancer	2.22e-05	0.000206	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—stomach cancer	2.21e-05	0.000205	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HRAS—stomach cancer	2.11e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KRAS—stomach cancer	2.1e-05	0.000195	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—stomach cancer	2.02e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	1.93e-05	0.000179	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—stomach cancer	1.87e-05	0.000173	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HRAS—stomach cancer	1.79e-05	0.000166	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—stomach cancer	1.71e-05	0.000159	CbGpPWpGaD
